Synchron vs Saluda Medical
Side-by-side comparison of AI visibility scores, market position, and capabilities
Synchron pioneers the world's first endovascular BCI (Stentrode) enabling paralysis patients to control devices with thoughts; raised $200M Series D (Nov 2025) totaling $345M, Apple BCI-HID integration achieved.
About
Synchron is a neurotechnology company developing brain-computer interface (BCI) technology using a minimally invasive endovascular surgical approach. Unlike conventional BCIs that require open-brain surgery to implant electrode arrays directly on the cortex, Synchron's Stentrode device is delivered through a catheter inserted via the jugular vein and positioned in a blood vessel adjacent to the motor cortex — requiring no open neurosurgery and dramatically reducing patient risk and recovery time. The Stentrode detects neural signals associated with intended movement and translates them into digital commands, enabling individuals with severe paralysis — from ALS, stroke, or spinal cord injury — to control computers, smartphones, and other devices using thought alone.
Saluda Medical is the pioneer of closed-loop spinal cord stimulation (SCS); FDA-approved Evoke SCS system with real-time neural feedback; raised $100M in Jan 2025; received FDA clearance for automated EVA programming platform.
About
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US operations in Marlborough, Massachusetts), Saluda''s flagship product is the Evoke Spinal Cord Stimulation (SCS) System — the world''s first SCS system that senses and measures neural responses to stimulation (evoked compound action potentials, or ECAPs) and automatically adjusts therapy in real time based on each patient''s neurophysiological feedback. This closed-loop approach provides more precise, consistent pain relief compared to conventional open-loop SCS systems.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.